| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |